Despite its involvement in hypertension onset, angiotensin II has been found to inhibit the insulin activity by its binding to the angiotensin type 1 receptor [89], which, in addition to NOX activation, contributes to the occurrence of vascular insulin resistance, endothelial dysfunction, apoptosis, and inflammation. The gene discussed is AGT; the disease is hypertensive disorder.